TG THERAPEUTICS, INC. Notes Payable, Current
TG THERAPEUTICS, INC. (TGTX) had Notes Payable, Current of $938.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2021-03-01
- 2020-12-31: Notes Payable, Current $938.00K.
- 2020-09-30: Notes Payable, Current $477.00K.
- 2020-06-30: Notes Payable, Current $343.00K.
- 2020-03-31: Notes Payable, Current $171.00K.
| Period end | Notes Payable, Current | Notes Payable, Current as first filed |
|---|---|---|
| 2020-12-31 | $938.00K 10-K · filed 2021-03-01 | |
| 2020-09-30 | $477.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $343.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $171.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $190.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $95.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $145.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $133.00K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $67.00K 10-K · filed 2020-03-02 | |
| 2018-09-30 | $91.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $210.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $224.00K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $128.00K 10-K · filed 2019-03-01 | $127.61K 10-K · filed 2018-03-15 |
| 2017-09-30 | $182.16K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $152.57K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $174.66K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $68.88K 10-K · filed 2018-03-15 | |
| 2016-09-30 | $117.13K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $90.56K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $152.92K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $211.55K 10-K · filed 2017-03-16 | |
| 2015-09-30 | $181.67K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $295.36K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $272.21K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $275.19K 10-K · filed 2016-03-15 | |
| 2014-09-30 | $183.14K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $159.21K 10-Q · filed 2014-07-24 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $677.78K 10-K · filed 2015-03-16 | |
| 2013-09-30 | $677.78K 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $677.78K 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $677.78K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $677.78K 10-K · filed 2014-03-07 | |
| 2012-09-30 | $677.78K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $677.78K 10-Q/A · filed 2012-09-07 | |
| 2012-03-31 | $677.78K 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $877.78K 10-K · filed 2013-03-21 | |
| 2011-09-30 | $761.31K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $775.29K 10-Q/A · filed 2011-09-14 | |
| 2010-12-31 | $2.05M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |